Disease | uveitis |
Symptom | C0271051|macular edema |
Sentences | 10 |
PubMedID- 23514443 | Ozurdex® (allergan, inc.) has already obtained fda approval for intravitreal use for macular edema due to non-infectious uveitis or retinal vein occlusions 5. |
PubMedID- 25134495 | Tofacitinib is fda approved for rheumatoid arthritis and sotrastaurin currently studied in phase 2 trials in patients with macular edema associated with uveitis offer examples of this approach, respectively. |
PubMedID- 24347829 | In one retrospective study, tocilizumab was found to be efficacious in treating uveitis patients with cystoid macular edema that was refractory to intraocular steroids or other immunosuppressive therapies . |
PubMedID- 20337324 | The case of a 44-year-old woman who was under treatment for bilateral recurrent anterior uveitis with chronic cystoid macular edema for two and a half years. |
PubMedID- 20714178 | More recently, increased clinical use of locally delivered gc has shown significant benefit for the treatment of multiple retinal indications including macular edema associated with uveitis, retinal vascular occlusions and diabetes. |
PubMedID- 24696869 | They offer an alternative route in the management of macular edema due to uveitis, retinal vein occlusion, diabetes and pseudophakia. |
PubMedID- 22783878 | Sustained-release intraocular implants have been approved for posterior uveitis and rvo associated with macular edema. |
PubMedID- 23807831 | macular edema is one of the manifestations of uveitis leading to loss of central vision and reduced visual acuity. |
PubMedID- 23786783 | Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial. |
PubMedID- 22661129 | Prior studies have shown that srds are found in 15–20 % of uveitis patients with macular edema , but there is conflicting literature as to the correlation between the presence of srd and decreased visual acuity. |
Page: 1